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Received February 15, 2012; accepted July 5, 2012AbstractBackground: Gamma-knife surgery (GKS) is ineffective for high-flow arteriovenous fistula (AVF). The purpose of this study was to present the
angioarchitecture of the AVF of brain arteriovenous malformation (BAVM) and report our experience of endovascular embolization of AVF
component prior to GKS.
Methods: In the past 10 years, a total of 523 BAVMs had been treated primarily by GKS. Among these, 10 patients with AVF components were
identified and referred for embolization prior to GKS. Those patients underwent GKS within 4 weeks after embolization. We analyzed retro-
spectively the angioarchitecture of the AVFs of BAVMs, selection of embolic materials for embolization, and treatment outcomes.
Results: The location of the AVFs was anterior (n ¼ 7) or middle (n ¼ 3) cerebral artery. Central and peripheral types of AVFs were found in
seven and three patients, respectively. Nine AVFs were totally occluded by a single session of endovascular embolization, while one failed to be
embolized because it was inaccessible to a microcatheter. Detachable coils (n ¼ 6) or combination of liquid adhesives (n ¼ 3) were selected to
embolize the AVF. No significant periprocedural neurological complication was found. BAVMs were obliterated totally by subsequent GKS in
six patients and partial occlusion was achieved in one, while three still awaited the effect of GKS. Mean imaging and clinical follow-up periods
were 35 and 48 months, respectively.
Conclusion: Early detection of the central type of AVF of BAVM prior to GKS may be difficult because of its overlapping with feeder, nidus,
and/or venous drains or it being overlooked. Peripheral-type AVFs were usually evident prior to GKS, particularly those with proximal dilated
venous drains. Endovascular embolization is an effective modality for managing these AVFs, which may be treated by GKS ineffectively.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Gamma-knife surgery (GKS) is an effective modality for
treatment of brain arteriovenous malformations (BAVMs). The
cure rate for BAVM at 2 years after GKS may be up to* Corresponding author. Dr. Chao-Bao Luo, Department of Radiology, Tai-
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http://dx.doi.org/10.1016/j.jcma.2013.01.01180e85% in some selected patients.1e4 However, GKS is
ineffective for high-flow arteriovenous fistula (AVF) of the
BAVM.5 Therefore, early identification and embolization of
the fistula component are essential to enhance the cure rate of
GKS for BAVM. In the past, the main role of embolization
was to target the weak points of BAVMs such as flow-related
or intra-nidus aneurysm or to reduce the size of large BAVMs,
to make the BAVM amenable to subsequent GKS and mini-
mize the risks during the latency.4,6,7 Early identification and
embolization of the AVF of BAVM prior to GKS have not
been well evaluated.hinese Medical Association. All rights reserved.
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neuroimaging identification, angioarchitecture analysis, and
endovascular embolization of the AVFs of BAVMs prior to GKS.
2. Methods
From August 2002 to July 2011, a series of 523 patients
with BAVMs were treated primarily by GKS in our hospital
(Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.).
Prior to GKS, all patients underwent brain magnetic resonance
imaging/angiography (MRI/MRA), and cerebral digital sub-
traction angiography (DSA) for an analysis of the angioarch-
itecture and cerebral blood-flow hemodynamics. Of these
patients, 10 were referred to our institute for evaluation of the
feasibility of endovascular embolization because the fistula
components were obvious, of high-flow, and presumed inef-
fective for GKS. That does not reflect the true incidence of the
fistula component in BAVM in our cohort. Patient 5 had
BAVM and had received GKS 3 years earlier, with a residual
BAVM. Prior to the initiation of this study, informed consent
was obtained from all 10 patients. All these AVFs were
assumed to be high-flow shunts because of larger feeders and
dilated proximal venous drains with various degrees of steal
phenomenon depicted by DSA. We graded the BAVM ac-
cording to the SpetzlereMartin proposal; in addition, the AVF
was classified as central or peripheral type based on whether
the fistula was located within or adjacent to the nidus of the
BAVM. The participants included six men and four women,
aged 6e56 years (mean: 37 years), who presented with
headache (n ¼ 8), seizure (n ¼ 5), dizziness (n ¼ 2), neuro-
logic deficit because of venous infarction (n ¼ 2), or hemor-
rhage (n ¼ 3).
Endovascular embolization of the AVF component of
BAVMs was performed using a transfemoral artery approachTable 1
Demographic and clinical outcomes in 10 patients with AVF components of BAV
Patient/sex/age
(y)
Clinical manifestations BAVM grading
(SpetzlereMartin)
Location
of BAVM/
1/M/6 Headache, dizziness 2 FP/ACA
2/F/44 Seizure, ICH 2 FP/ACA
3/F/27 Headache, dizziness 3 F/ACA
4/M/50 Neurologic deficit, headache 3 F/ACA
5/M/37 Seizure, headache 4 T, BG/MC
6/F/32 Seizure, headache, ICH 3 F/ACA
7/M/53 Seizure 3 TP/MCA
8/F/39 Neurologic deficit,
headache, ICH
3 FP/ACA
9/M/56 Headache 3 F/ACA
10/M/25 Seizure, headache 4 T, BG/MC
ACA ¼ anterior cerebral artery; AVF ¼ arteriovenous fistula; BAVM ¼ brain arteri
knife surgery; ICH ¼ intracerebral hemorrhage; MCA ¼ middle cerebral artery; Nunder general anesthesia. Systemic heparinization was ach-
ieved by administering an intravenous bolus of heparin
(3000 IU) and maintained by a continuous intravenous infu-
sion of heparin (1500 IU/h). Activated clotting time was
measured every half hour during the procedure and maintained
at a value that was about twice the baseline value. A 6-F
guiding catheter was positioned in the internal carotid artery.
Then, a wire-guiding microcatheter (SL-10; Boston Scientific
Corporation, Fremont, CA, USA) was introduced and navi-
gated to pass through the fistula coaxially. After the position of
the microcatheter tip was wedged in the fistula component,
detachable coils (Boston Scientifics, Fremont, CA, USA, or
Microvention, Aliso Viejo, CA, USA) were introduced in nine
patients through the microcatheter into the distal parent artery
to the fistula and the proximal venous pouch. In three patients
with larger proximal venous pouch with subtotal occlusion of
the fistulas by coil depositions, a mixture of 50% N-butyl-
cynoacrylate (NBCA; Nycomed, Ingenor, Paris, France) and
Lipiodol Ultra-Fluide (Laboratoire Guerbet, France) (about
0.4e0.8 mL) was infused into the AVFs through the micro-
catheter. The injection of the NBCA was preceded by the
administration of 5% dextrose.
A postembolization DSA was performed immediately after
the completion of the procedure to check for occlusion of the
fistula. All patients underwent GKS within 4 weeks after
embolization. All patients received clinical and/or MRI
follow-up (mean: 48 and 35 months, respectively). To follow
the progression of BAVMs (mean: 39 months), DSA was
performed in nine patients.
3. Results
The clinical findings and treatment outcomes of 10 patients
are summarized in Table 1. Six BAVMs were of Grade 3,Ms after embolization and GKS.
fistula
Type of
AVF
Embolic
agent(s)
Outcome Clinical/imaging
follow-up (mo)
Peripheral Coils Cure 67/56
Central Coils,
NBCA
Cure 52/39
Central Coils,
NBCA
Cure 74/53
Central Coils,
NBCA
Small
residual
BAVM
45/35
A Peripheral Coils Cure 65/43
Central Coils Await the
effect of GKS
23/15
Central Coils Cure 54/42
Central Coils Cure 58/35
Central Coils Await the
effect of GKS
26/17
A Peripheral Failure to access Await the
effect of GKS
14/12
ovenous malformation; BG ¼ basal ganglia; F ¼ frontal lobe; GKS ¼ gamma-
BCA ¼ N-butyl-cynoacrylate; P ¼ parietal lobe; T ¼ temporal lobe.
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found in two patients in each group. The location of the AVFs
was anterior (n ¼ 7, Figs. 1 and 2) or middle (n ¼ 3) cerebral
artery. Regarding venous drains of AVF/BAVM, single su-
perficial venous drains were found in three patients, multiple
superficial venous drains were found in four patients, and
multiple superficial and deep venous drains were found in
three patients. Detachable coils were selected to occlude the
fistula in six patients (Fig. 2) and combinations of detachable
coils and liquid adhesives were used in three patients (Fig. 1).
Complete fistula occlusion was achieved in nine patients with
AVFs in a single session of embolization (Figs. 1 and 2). In
one patient, we failed to access and embolize peripheral AVF
because of the markedly tortuous feeder of the anterior
choroid artery; subsequently, the patient underwent GKS
alone. No significant procedure-related neurological compli-
cation such as intracranial hemorrhage or infarction was
observed in nine patients undergoing embolization. Follow-up
DSA was performed in seven of nine patients undergoing
embolization, which demonstrated no evidence of fistula
recurrence. The MRI and/or DSA outcomes of BAVMs after
GKS were total obliteration in six patients, still awaiting the
effect of GKS in three patients (follow-up less than 24
months), and residual BAVMs in one. Complete (n ¼ 6) and
partial regression (n ¼ 2) of the symptoms were found in eight
patients, while two patients remained stable with medication.
4. Discussion
GKS, which is a less invasive modality for managing
BAVM, shows promising results. However, it fails to cure
about 20e30% of patients.9,10 The 3-year follow-up DSA
showed several factors related to the failure of GKS for
BAVMs. These included inadequate nidus definition, large
nidus volume, suboptimal radiation dose, and radio resistance
because of high-flow AVF component.1e5,9,10
AVF is a direct shunt between an arterial feeder and its
venous drain without intervening arteriovenous nidus. The
fistula can be categorized as a low- or a high-flow shuntFig. 1. A 27-year-old woman had Grade 3 BAVMs in the left frontal lobe. (A) Lef
(arrows) in the left anterior cerebral artery. (B) The patient underwent endovasc
mixtures, leading to total fistula occlusion (C). Follow-up carotid angiogram
AVF ¼ arteriovenous fistula; BAVM ¼ brain arteriovenous malformation; GKS ¼depending on the size of the shunt and the steal phenomenon.
In a high-flow AVF, it is usually a single fistula with a large
shunt having a short and direct route, and the blood flow is
high and rapid, with a moderate to severe steal phenomenon
because of the large pressure gradient between the artery and
the venous system. Sequelae of intracranial AVFs include an
arterial steal phenomenon with cerebral hypoperfusion and an
increased flow in cerebral veins resulting in intracranial
venous congestion, ischemic change, or hemorrhage. Because
the majority of high-flow AVFs are supplied by larger feeders
with relatively short and directed routes, endovascular embo-
lization is an effective and safe modality to manage these
AVFs, with promising outcomes.5,11
The BAVM associated with AVF is not uncommon. The
existence of a high-flow AVF was reported to cause failure of
GKS treatment in 5.8% of patients with BAVMs.9 Therefore,
early identification and embolization of the fistula component
of BAVM prior to GKS are essential to enhance the success
rate of complete obliteration of the BAVM. In this study we
classified the BAVM-associated high-flow AVF into two types,
central and peripheral. Central type of AVF is more common
and usually mixes with nidus part of the BAVM. These fistulas
are usually difficult to detect by neuroimaging prior to GKS
because of their superimposition with feeders, nidus, or
venous drains. However, if DSA demonstrated an enlarged
venous pouch in the nidus part with earlier contrast opacifi-
cation than other venous drains, the central type of AVF
should be suspected. On the contrary, the peripheral type of
AVF located on the periphery of the BAVM nidus can usually
be clearly detected by its larger feeders with dilated venous
drains. Occasionally, the peripheral type of fistula component
of the BAVM may be confused with a coexistence of isolated
cerebral AVF. An isolated cerebral AVF is usually located in a
different arterial territory and has its own venous drain prior to
draining into the dural sinus. By contrast, the peripheral type
of AVF of the BAVM has common venous outflow drains with
the nidus part.
With regard to the imaging evaluation of angioarchitecture
of the BAVM, MRI/MRA is a good and noninvasive toolt frontal carotid angiogram depicted BAVM with a high-flow central-type AVF
ular embolization of the AVF by employing the detachable coils and NBCA
at 49 months after GKS showed total occlusion of the BAVM and AVF.
gamma-knife surgery; NBCA ¼ N-butyl-cynoacrylate.
Fig. 2. A 6-year-old boy presented with Grade 2 BAVMs in the right frontoparietal lobes. (A and B). Bilateral frontal carotid angiograms demonstrated BAVM with
an obvious high-flow AVF with dilated venous drains (arrows). (C) Postembolization carotid angiogram revealed total fistula occlusion by employing detachable
coils (D and E). Follow-up carotid angiogram at 56 months after GKS showed total obliteration of the BAVM and AVF. AVF ¼ arteriovenous fistula;
BAVM ¼ brain arteriovenous malformation; GKS ¼ gamma-knife surgery.
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the BAVM and demonstrate its relationship with nearby brain
tissue. Furthermore, it is a very useful modality to monitor the
progression of the BAVMs and the presence of any adverse
radiation effects after GKS. However, the major concerns
about MRA are its incapacity/inability to demonstrate cerebral
blood-flow hemodynamics and that it may have difficulties in
illustrating the real size of the nidus component and the
presence of the AVF component of the BAVM. Conventional
global cerebral DSA is the current reference and gold standard
for the diagnosis, assessment, and management of BAVMs.
However, in the absence of superselective micro-
catheterization and injection, a precise definition of nidus
angioarchitecture including the fistula component is almost
impossible because it may overlap with feeder, nidus, and
venous drains, particularly those of central types. To search for
the associated AVF and enhance the success rate of subsequent
GKS for the treatment of BAVMs, Pollock et al10 have applied
microcatheter superselective angiography (MSA) as a part of
pretherapeutic evaluation. MSA can clarify and delineate AVF
within the nidus. The second advantage of MSA is that it may
allow the immediate treatment of AVF with an acceptable low
risk of morbidity and mortality, and reduce the risk of
neurologic deficit or hemorrhage during the latency after GKS.
However, the disadvantages of MSA are that it is timeconsuming and the use of a microcatheter to search for the
potential AVF is too expensive if embolization is not initiated.
In addition, it may increase procedural risks such as those of
an thromboembolic event or an arterial injury. In our study,
only 10 out of 523 patients (1.9%) with AVF components were
identified early and referred for embolization. This low rate of
identification of fistula components likely reflects the over-
looking of the AVF, ignoring of its superimposition onto
feeder/nidus/venous drains, or lack of MSA to search for its
presence. Theoretically, the AVF part may become obvious
once the majority of nidus is obliterated by GKS.
At the present time, most embolizations of BAVMs have
been conducted prior to GKS, with many positive effects and
promising results. However, pre-GKS embolization might it-
self be a negative predictor for patient outcome. In a multi-
variate analysis of 19 incomplete obliterations after BAVM
GKS, three (16%) had recanalization of a portion of the
BAVM after embolization12e14; therefore, repeat GKS was
required. Previously embolized BAVMs may also make dose
planning more difficult if the resultant shape of the BAVM is
irregular or has been divided into multiple compartments.
Furthermore, embolization carries inherent periprocedural
risks, such as intracranial hemorrhage or ischemic stroke.
Recognition of the limitations and risks of embolization as an
adjunct to pre-GKS has led our team to decide to treat AVFs
281C.-B. Luo et al. / Journal of the Chinese Medical Association 76 (2013) 277e281only. The nidus parts of the BAVM are usually ignored and
managed by subsequent GKS.
As to the selection of the microcatheter and embolic agent,
it largely depends on the fistula anatomy and flow character-
istics. If the high-flow fistulas are fed by a short and directed
parent artery and can be accessed by a wire-guided micro-
catheter from arterial to venous sites, we prefer to select
detachable coils for occluding the AVF, because the procedure
can be controlled easily and coils can be deposited precisely
into the venous sac, fistula, and its proximal parent artery,
leading to total occlusion of the fistula.11 In our study, to
enhance the effect of fistula occlusion and to decrease the
number of coils and cost, variable amounts of NBCA mixtures
were infused into the residual fistula after subtotal fistula oc-
clusion in four AVFs. In this study, we did not select NBCA or
Onyx alone as an embolizer, largely because they are liquid
embolic agents. It is difficult to control their flow and depo-
sition after injection. In addition, embolization of high-flow
fistula by selection of liquid embolic agents may have the
risk of distal migration of embolizer to venous drains, leading
to catastrophic complications such as venous infarction or
nidus rupture because of occlusion of the outlet, particularly
when the AVF/BAVM have only single venous drains.
In conclusion, BAVM associated with a high-flow AVF may
be found occasionally prior to GKS. It can be of central or
peripheral type. Early identification of the central type may be
difficult by conventional neuroimages due to its superimpo-
sition with nidus, feeder, and/or venous drains or it being
overlooked. On the contrary, the majority of peripheral AVFs
usually are evident prior to GKS. Endovascular embolization
is feasible and effective in managing these high-flow fistulas,
and may enhance the successful cure rate of subsequent GKS.
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